The teams behind two new studies explored very different ways to predict severe illness or death among hospitalized COVID-19 patients. 

Some high-risk patients died during the delay, the research team reported. 

One key finding reported by the research team was a substantial decrease in AFib readmissions. 

The researchers think their findings may explain why so many cancer survivors go on to experience heart failure.

The new guidelines come straight from the American College of Cardiology. 

The analysis, written by representatives of the American Heart Association, focused on SGLT2 inhibitors and GLP-1 receptor agonists.

COVID-19 has showcased the power and practicality of wearable cardiac monitoring devices for patients and physicians. Many expect the trend toward digitization will only accelerate.

Researchers at Columbia University have developed a machine learning algorithm that identifies and predicts gender-based differences in adverse reactions to drugs.